XT
MGRX icon

XTX Topco’s Mangoceuticals MGRX Stock Holding History

XTX Topco’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.8K Buy
186,256
+173,114
+1,317% +$66.7K ﹤0.01% 3627
2026
Q1 		$4.73K Buy
+13,142
New +$6.3K ﹤0.01% 3754
2025
Q4 		– Sell
-28,514
Closed -$62.4K – 3604
2025
Q3 		$62.4K Buy
+28,514
New +$53.1K ﹤0.01% 2126
2024
Q4 		– Sell
-1,922
Closed -$6.8K – 2690
2024
Q3 		$6.8K Buy
+1,922
New +$9.07K ﹤0.01% 1960
2024
Q2 		– Sell
-1,623
Closed -$5.36K – 2230
2024
Q1 		$5.36K Buy
+1,623
New +$6.46K ﹤0.01% 1716

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

XTX Topco's MGRX Position: Q2 2026 in Review

XTX Topco increased its Mangoceuticals (MGRX) stake by 1,317% in Q2 2026, buying an estimated $66.7K and bringing the position to 186,256 shares worth $70.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3627.

XTX Topco first reported a position in MGRX in Q1 2024 and has held it in 5 quarters since. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • XTX Topco held 186,256 shares of Mangoceuticals worth $70.8K as of Q2 2026.
  • XTX Topco bought 173,114 Mangoceuticals shares in Q2 2026, an estimated $66.7K.
  • Mangoceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3627 holding.
  • XTX Topco first reported a position in Mangoceuticals in Q1 2024 and has held it in 5 quarters since.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.